期刊文献+

右旋美托咪定对脓毒血症大鼠心功能障碍的影响 被引量:2

Influence of dexmedetomidine on cardiac dysfunction in rats with sepsis
下载PDF
导出
摘要 目的观察右旋美托咪定对脓毒血症大鼠心功能障碍的影响。方法 30只SD大鼠随机均分假手术(Sham)组、盲肠结扎穿孔(CLP)组和右旋美托咪定(Dex)组,每组各10只。采用盲肠结扎穿孔法建立大鼠脓毒血症模型。Dex组大鼠建模后即给予负荷量的右旋美托咪定7μg/kg,20 min后以5μg/(kg·h)持续泵注,其余两组均于术后持续泵注等量生理盐水。采集术后6 h、12 h、24 h时的平均动脉压(MAP)、心率(HR)、左心室舒张末压(LVEDP)、左心室收缩压(LVSP)、左心室最大收缩速率(+d P/dt),左室最大舒张速率(-d P/dt)。采用ELISA试剂盒法检测血清中血清脂联素、肿瘤坏死因子-α(TNF-α)及白细胞介素-1β(IL-1β)水平。结果与Sham组比较,CLP组与Dex组大鼠在术后6 h、12 h和24 h的血流动力学指标MAP、HR、LVEDP、LVSP、+d P/dt和-d P/dt及24 h的血清脂联素、TNF-α及IL-1β水平均明显均明显降低(P<0.05)。与CLP组比较,Dex组大鼠在术后6 h、12 h和24 h的血流动力学指标MAP、HR、LVEDP、LVSP、+d P/dt及-d P/dt均明显升高(P<0.05),术后24 h时血清脂联素水平升高、TNF-α及IL-1β水平明显减少(P<0.05)。结论 Dex可明显改善脓毒血症大鼠心功能障碍并维持血流动力学稳定,其作用可能与上调血清脂联素表达水平、抑制TNF-α和IL-1β炎症因子表达,减轻脓毒症所致心脏毒性和心肌损伤有关。 Objective To observe the influence of dexmedetomidine on cardiac dysfunction in rats with sepsis. Methods SD rats(n=30) were randomly divided into sham-operation group(Sham group), cecal ligation and puncture group(CLP group) and dexmedetomidine group(Dex group, each n=10). The rat model of sepsis was established by applying CLP. Dex group was given load dose of Dex(7 μg/kg, and 5 μg/kg·h after 20 min), and other 2 groups were given the same dose of normal saline solution. The changes of mean arterial pressure(MAP), heart rate(HR), LVEDP, LVSP, +d P/dt and-d P/dt were observed after CLP for 6 h, 12 h and 24 h respectively. The levels of serum adiponectin(ADP), tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) were detected by using ELISA. Results Compared with Sham group, MAP, HR, LVEDP, LVSP, +d P/dt and-d P/dt after 6 h, 12 h and 24 h, and levels of serum ADP, TNF-α and IL-1β after 24 h decreased significantly in CLP group and Dex group(P〈0.05). Compared with CLP group, MAP, HR, LVEDP, LVSP, +d P/dt and-d P/dt after 6 h, 12 h and 24 h increased significantly(P〈0.05), level of serum ADP increased and levels of TNF-α and IL-1β decreased significantly(P〈0.05) in Dex group after 24 h. Conclusion Dex can significantly relieve cardiac dysfunction and maintain stable hemodynamics in sepsis rats, and the effect maybe related to up-regulating serum ADP, inhibiting TNF-α and IL-1β, and abating sepsis-induced cardiotoxicity and myocardial injury.
出处 《中国循证心血管医学杂志》 2015年第6期843-845,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 右旋美托咪定 脓毒血症 心功能障碍 Dexmedetomidine Sepsis Cardiac dysfunction
  • 相关文献

参考文献13

  • 1孟强,董伟,屈峰.早期血液滤过对脓毒血症患者血浆IL-10和单核细胞人白细胞抗原-DR表达的影响[J].中国医学创新,2014,11(7):6-8. 被引量:20
  • 2Gamkrelidze M,Intskirveli N,Vardosanidze K,et al. Myocardial dysfunction during septic shock (review)[J]. Georgian Med News,2014,(237):40-6.
  • 3Walley KR. Deeper understanding of mechanisms contributing to sepsis-induced myocardial dysfunction[J]. Crit Care.2014, 18(3): 137.
  • 4Giovannitti JA Jr,Thoms SM,Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications[J]. Anesth Prog,2015, (1):31-9.
  • 5Zhang X,Zhao X,Wang Y. Dexmedetomidine: a review of applications for cardiac surgery during perioperative period[J]. J Anesth,2015, 29(1):102-11.
  • 6Mantz J,Josserand J,Hamada S. Dexmedetomidine:new insights[J]. Eur J Anaesthesiol. 2011,28(1):3-6.
  • 7Hu D,Yang X,Xiang Y,et al. Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response[J]. Cell Immunol. 2015,295(2):92-8.
  • 8Zhang J,Wang Z,Wang Y,et al. The effect of dexmedetomidine on inflammatory response of septic rats[J]. BMC Anesthesiol. 2015, 1(15):68.
  • 9于冬梅,张铁铮,周锦,陈克研,曹惠鹃.右美托咪定对内毒素血症大鼠急性肾损伤的保护作用[J].实用药物与临床,2014,17(12):1545-1547. 被引量:7
  • 10Kimmoun A,Ducrocq N,Levy B. Mechanisms of vascular hyporesponsiveness in septic shock[J]. Curr Vasc Pharmacol,2013, 11(2):139-49.

二级参考文献42

  • 1崔乃强,吴咸中.重症急性胰腺炎治疗的现况和展望[J].中国危重病急救医学,2004,16(12):705-707. 被引量:107
  • 2Angus D C, Linde-Zwirble W T, Lidicker J, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care[J]. Crit Care Med, 2001, 29 ( 7 ) : 1303- 1310.
  • 3Gogos A, Drosou E, Bassaris H P, et al. Pro-versus anti-inflammatory cytokine profile ih patients with severe sepsis: a marker for prognosis and future therapeutic options[J]. J Infect Dis, 2000, 181 ( 1 ) : 176- 180.
  • 4Hatherill M, Tibby S M, Turner C, et al. Proealcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock[J]. Crit Care Med, 2000, 28 ( 7 ) : 2591-2594.
  • 5Eskandari M K, Bolgos G, Miller C, et al. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia[J]. J Immunol, 1992, 148 (9) : 2724- 2730.
  • 6Echtenaeher B, Weigl K, Lehn N, et al. Tumor necrosis factor- dependent adhesions as a major protective mechanism early in septic peritonitis in mice[J]. Infect Immun, 2001, 69 ( 6 ) : 3550-3555.
  • 7Ruffell A J. The utilization of continuous veno-venous hemofiltration for the removal of septic mediators in patients with systemic inflammatory response syndrome[J]. Intensive Crit Care Nuts, 2003, 19 (4) : 207-214.
  • 8Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration[J]. Kidney Blood Press Res, 2003, 26 (2) : 128-134.
  • 9Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients[J]. Nephrol Dial Transplant, 2001, 16 ( 5 ) : 67-72.
  • 10Peng Z, Pal P, Hong-Bao L, et al. The impacts of continuous veno- venous hemofihratiou on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients[J]. Cytokine, 2010, 50 (2) : 186-191.

共引文献23

同被引文献20

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部